• / Free eNewsletters & Magazine
  • / My Account
Home>China’s New Prescription

China’s New Prescription

Perspectives Content Submission

Tue, 26 Apr 2011

Matthews has long followed the progress of China’s health care reform, and seen positive changes to the industry since the government announced its US$125 billion health care reform plan in 2009. One major change has involved improvements to the intellectual property (IP) protection for new pharmac
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.